Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL850P is a **pseudogene** derived from RNA, 7SL, cytoplasmic, which encodes the RNA component of the signal recognition particle (SRP)[1][4]. SRP RNA (7SL RNA) plays a crucial role in protein synthesis as part of the SRP ribonucleoprotein complex, mediating the targeting of secretory proteins to the endoplasmic reticulum[3][7]. However, RN7SL850P itself is a **pseudogene**: it is a nonfunctional genomic copy of the parent 7SL RNA gene, generated by the reverse flow of genetic information from functional 7SL RNA into genomic DNA; such pseudogenes are typically not transcribed or translated into functional RNA or protein[5]. Most 7SL pseudogenes, including RN7SL850P, do not have known direct biological or disease roles, nor established interactions with drugs or relevance as biomarkers. There is no evidence RN7SL850P is a therapeutic target[1][4]. Notes: - RN7SL850P is not a receptor, enzyme, transporter, or protein-coding gene but rather a **processed RNA pseudogene**. - Most sequence databases and gene nomenclature authorities, such as HGNC and GeneCards, list RN7SL850P as a locus type "pseudogene"[1][4]. - The functional 7SL RNA (not this pseudogene) is significant for cell biology, but RN7SL850P itself does not participate in SRP complex assembly or function. - The entry is not considered a therapeutic target, and its inclusion as a target may be incorrect. - If you are seeking information on the parent functional molecule, search for "7SL RNA" or "Signal recognition particle RNA"[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 850, pseudogene (RN7SL850P).